Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population - Summary - MDSpire

Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population

  • By

  • Hillary Samples

  • Sharon Cook

  • Jialiang Hua

  • Peter Treitler

  • Elizabeth M. Stone

  • Jennifer Miles

  • Mark Olfson

  • Stephen Crystal

  • January 13, 2026

  • 0 min

Share

Objective:

To examine medication for opioid use disorder (MOUD) initiation after acute care encounters for opioid overdose and its association with individual and community characteristics, including socioeconomic status and access to healthcare resources.

Key Findings:
  • High rates of opioid overdose ED visits compared to deaths indicate acute care settings are critical for intervention, highlighting the need for immediate action.
  • Low rates of post-overdose MOUD initiation were observed, with most individuals having prior treatment, suggesting a need for better engagement strategies.
  • Limited data on new treatment initiation in publicly insured populations highlights a gap in understanding treatment engagement and the need for targeted outreach.
Interpretation:

The study underscores the need for improved strategies to connect overdose survivors to MOUD, particularly in the Medicaid population, to significantly reduce the risk of repeat overdoses and fatalities.

Limitations:
  • Data limited to Medicaid claims may not represent all opioid overdose cases, potentially skewing the findings.
  • Potential underreporting of MOUD initiation and treatment patterns may affect the accuracy of the results.
Conclusion:

Enhancing access to MOUD following overdose events is essential for improving outcomes in the Medicaid population, necessitating targeted interventions.

Original Source(s)

Related Content